A AGENUS B.E.S.T. BIOTECH ELECTRONIC SECURITY TOKEN
associated with 40 other trademarks
Digital securities; digital securities backed by future sales of an experimental cancer drug; providing investment options in the nature of securities...

Words that describe this trademark:

experimental cancer drug  drug investment  cancer drug  digital securities  securities backed  future sales  sales  securities  backed 

Serial Number:

88282311

Mark:

A AGENUS B.E.S.T. BIOTECH ELECTRONIC SECURITY TOKEN

Status:

Abandoned-Failure to Respond

Status Date:

10-31-2019

Filing Date:

Registration Number:

N/A

Registration Date:

N/A

Goods and Services:

Digital securities; digital securities backed by future sales of an experimental cancer drug; providing investment options in the nature of securities backed by drug sales

Mark Description:

The mark consists of the stylized representation of a token featuring a circle within a circle, with a curved line on the left and right sides in between the borders of the two circles, with the letter "a" in the center of the inner circle and the words "BIOTECH ELECTRONIC" curved above it and "SECURITY TOKEN" curved below it, and the word "AGENUS" curved in the top center border between the two circles, and the word "B.E.S.T." curved in the bottom center border between the two circles.

Class:

Advertising

Type of Mark:

Servicemark

Published for Opposition Date:

N/A

Mark Drawing Status:

Design plus Words, Letters, and/or Numbers

Abandon Date:

10-02-2019

Business Name:

WOLF, GREENFIELD & SACKS, P.C.

Correspondent Name:

Recent Trademark filings by this company